WSJ
14 Sept 2026, 09:30 UTC · 2h ago
Verdict
Headline leans bullish. We score LLY −0.40 across two claims.
Score contradicts the headline.
LLY score
−0.40
More negative than 75% of ticker scores this week
Price reaction
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · scored −1 bearish … +1 bullish
Bootleg versions of an experimental Eli Lilly drug are flooding the market.
More negative than 91% of claims this week
Regulators are actively attempting to curb the supply of these bootleg drugs.
More positive than 66% of claims this week
Continue reading
5 related stories
Analysis by Kasper Rasmussen · Founder & analyst
Which stocks this story touches
More negative than 75% of ticker scores this week
The company is facing issues with bootleg versions of its experimental drug flooding the market.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
14h ago
Price reaction
Expected −0.40Actual —
LLY hasn't traded since this ran. Last close $1115.25 (Sep 11); the reaction starts at the next open.
LLY chart →
